SAM
RCUS icon

Smartleaf Asset Management’s Arcus Biosciences RCUS Stock Holding History

Smartleaf Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.84K Sell
186
-108
-37% -$2.33K ﹤0.01% 2772
2025
Q4 		$6.83K Buy
294
+293
+29,300% +$5.98K ﹤0.01% 2566
2025
Q3 		$13 Buy
+1
New +$10 ﹤0.01% 2997
2024
Q4 		– Sell
-21
Closed -$323 – 2999
2024
Q3 		$323 Buy
21
+8
+62% +$126 ﹤0.01% 2837
2024
Q2 		$197 Buy
+13
New +$210 ﹤0.01% 2677

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Smartleaf Asset Management's RCUS Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Arcus Biosciences (RCUS) stake by 37% in Q1 2026, selling an estimated $2.33K and leaving 186 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Smartleaf Asset Management first reported a position in RCUS in Q2 2024 and has held it in 5 quarters since. The position peaked at $6.83K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Smartleaf Asset Management held 186 shares of Arcus Biosciences worth $3.84K as of Q1 2026.
  • Smartleaf Asset Management sold 108 Arcus Biosciences shares in Q1 2026, an estimated $2.33K.
  • Arcus Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2772 holding.
  • Smartleaf Asset Management first reported a position in Arcus Biosciences in Q2 2024 and has held it in 5 quarters since.
  • Smartleaf Asset Management's Arcus Biosciences position peaked at $6.83K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.